COVID-19 大流行期间丹麦一家大型急救医院工作人员的血清转化
The aim of this study is to apply serology testing methods for SARS-CoV2 antibodies in samples collected from HCWs in an acute hospital. This will enable the identification of those who are protected and non-infectious for SARS-CoV2 and those who are seronegative and therefore potentially susceptible and infectious on patient contact. Prospective testing will provide data on the acquisition of SARS-CoV2 infections among HCWs and associated risk factors for transmission during a pandemic at an acute care hospital facility in the capital region of Denmark.
Hypothesis: Serial seroconversion measurements in hospital employees improve the organization of the clinical treatment and care during the COVID-19 pandemic at Nordsjællands Hospital and Nykøbing Falster County Hospital.
研究概览
地位
详细说明
The study is a prospective cohort study. Weekly (in the first phase) and bi-weekly (in the second phase) serum samples will be drawn and shipped bi-weekly to laboratory collaborators in United Kingdom for antibody analyses during the course of the local epidemic, expected to last 10-12 weeks or more. After the cease of the epidemic serum will be drawn in 3-monthly intervals in a smaller group of seroconverted volunteers to follow the long-lasting immunity of SARS-CoV-2 infection up to 5 years post-pandemic.
Nurses, medical doctors, biomedical laboratory scientists, social health care assistants, and few healthcare administrators (as controls) will be invited for enrolment. In hospitals, all departments with staff that are in physical contact with patients during the pandemic will be invited to participate in the study.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Capital Region
-
Hillerød、Capital Region、丹麦、3400
- Nordsjællands Hospital
-
-
Southern Region
-
Nykøbing Falster、Southern Region、丹麦、4800
- Nykøbing Falster County Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Health care workers at two Danish hospitals
描述
Inclusion Criteria: hospital employee
-
Exclusion Criteria: none
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Serial seroconversion measurements in hospital employees
Serial seroconversion measurements in hospital employees during the COVID-19 pandemic |
The aim of this study is to apply serology testing methods for SARS-CoV2 antibodies in samples collected from HCWs in an acute hospital. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Serology testing for specific COVID-19
大体时间:From baseline to follow up at four years
|
IgM and IgG (Covid-19 antibodies) |
From baseline to follow up at four years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
SARS-CoV-2 infection
大体时间:From baseline to follow up at three months
|
Swab, SARS-CoV-2 |
From baseline to follow up at three months
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Co-variates
大体时间:At baseline
|
Age, gender, employment details, smoking, chronic diseases |
At baseline
|
合作者和调查者
调查人员
- 首席研究员:Thea K Fischer, professor、Nordsjaellands Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.